GlassScriptPhysician profile
Cynthia Plate
NPI 1972579753
$11,119.92
in general payments reported to CMS, 2019-2025
76 companies · $2,391 in 2025
The $2,391 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $34.83 · 2021: $1,212 · 2022: $1,858 · 2023: $2,566 · 2024: $2,844 · 2025: $2,391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,801.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $893.55 | 2021-2025 | |
| Molli Surgical (US) INC | $891.38 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $686.76 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Janssen Biotech, INC. | $673.29 | 2021-2025 | Tecvayli, Darzalex, Talvey |
| Astrazeneca Pharmaceuticals LP | $539.58 | 2021-2025 | Imfinzi, Lynparza, Calquence |
| Daiichi Sankyo INC. | $427.40 | 2022-2025 | Enhertu, Injectafer, Vanflyta |
| Glaxosmithkline, LLC. | $383.57 | 2021-2025 | Zejula, Jemperli |
| Eisai INC. | $331.92 | 2021-2025 | |
| Stryker Corporation | $320.81 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $312.90 | 2021-2025 | Libtayo |
| Incyte Corporation | $265.49 | 2021-2025 | Monjuvi, Jakafi, Pemazyre |
| Lilly USA, LLC | $256.54 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Seagen INC. | $252.49 | 2021-2023 | Tukysa, Tivdak, Adcetris |
| Pharmaessentia USA Corporation | $247.33 | 2022-2025 | Besremi |
| Aveo Pharmaceuticals, INC. | $232.58 | 2022-2025 | Fotivda |
Show all 76 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $228.36 | 2021-2025 | Fruzaqla, Ninlaro, Vpriv |
| Adc Therapeutics America, INC. | $221.78 | 2022-2025 | |
| Amgen INC. | $198.19 | 2021-2023 | Xgeva, Vectibix, Nplate |
| Bayer Healthcare Pharmaceuticals INC. | $175.61 | 2021-2025 | |
| Taiho Oncology, INC. | $166.83 | 2022-2025 | |
| Ipsen Biopharmaceuticals, INC | $163.72 | 2021-2024 | Tazverik, Onivyde, Somatuline Depot |
| Exelixis INC. | $148.26 | 2021-2025 | Cabometyx |
| Genzyme Corporation | $134.87 | 2021-2025 | |
| Sobi, INC | $133.17 | 2022-2025 | |
| Kci USA, INC. | $121.13 | 2019 | |
| Pharmacosmos Therapeutics INC. | $118.19 | 2021-2024 | Monoferric |
| Tersera Therapeutics LLC | $117.19 | 2023-2025 | Xermelo, Zoladex |
| Abbvie INC. | $111.95 | 2021-2025 | |
| Genentech USA, INC. | $109.69 | 2022-2025 | Venclexta, Rozlytrek, Avastin |
| E.R. Squibb & Sons, L.L.C. | $109.67 | 2022 | |
| Kyowa Kirin, INC. | $107.61 | 2022-2024 | Poteligeo |
| Rigel Pharmaceuticals, INC. | $104.20 | 2021-2025 | Rezlidhia, Tavalisse, Gavreto |
| Genmab U.S., INC. | $102.30 | 2023-2025 | Epkinly |
| Tactile Systems Technology INC | $86.48 | 2021-2025 | Nimbl, Flexitouch Plus |
| Karyopharm Therapeutics INC. | $82.13 | 2022-2024 | Xpovio |
| Stemline Therapeutics INC. | $80.26 | 2023-2025 | Orserdu |
| Puma Biotechnology, INC. | $73.33 | 2021-2025 | |
| Servier Pharmaceuticals LLC | $70.34 | 2021-2024 | |
| Covidien LP | $67.78 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.85 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $60.39 | 2024-2025 | Orgovyx |
| Mallinckrodt Enterprises LLC | $59.36 | 2019 | |
| Davol INC. | $56.76 | 2023-2024 | Arista Ah Flexitip |
| Global Blood Therapeutics, INC. | $52.59 | 2022 | |
| Pfizer INC. | $52.09 | 2021-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $52.08 | 2021 | |
| Eusa Pharma (US) LLC | $49.63 | 2021-2022 | |
| Deciphera Pharmaceuticals INC. | $49.11 | 2021-2025 | Qinlock, Tgct |
| Agios Pharmaceuticals, INC. | $48.36 | 2024 | Pyrukynd |
| Janssen Pharmaceuticals, INC | $46.09 | 2021-2025 | Erleada |
| Springworks Therapeutics, INC. | $44.02 | 2024-2025 | Ogsiveo |
| Beone Medicines USA, INC. | $43.67 | 2025 | Brukinsa |
| G1 Therapeutics, INC. | $43.65 | 2023 | Cosela |
| Myriad Genetic Laboratories, INC. | $43.51 | 2021-2023 | Precisetumor |
| Morphosys, US INC. | $41.06 | 2021-2022 | |
| Blueprint Medicines Corporation | $40.80 | 2021-2022 | |
| Boston Scientific Corporation | $40.67 | 2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Array Biopharma INC | $39.48 | 2021-2025 | Braftovi, Lorbrena, Mektovi |
| Tolmar Pharmaceuticals, INC. | $37.95 | 2021-2022 | |
| Mirati Therapeutics, INC. | $35.45 | 2023 | Krazati |
| Astellas Pharma US INC | $33.89 | 2025 | Cresemba |
| Alexion Pharmaceuticals, INC. | $33.20 | 2024 | Ultomiris |
| Alnylam Pharmaceuticals INC. | $25.95 | 2021-2023 | Givlaari |
| Immunogen, INC. | $25.15 | 2023 | Elahere |
| Tg Therapeutics, INC. | $24.89 | 2021 | |
| Fresenius Kabi USA, LLC | $24.43 | 2025 | Stimufend |
| Invivyd INC | $23.64 | 2024 | Pemgarda |
| Telix Pharmaceuticals | $23.35 | 2023 | Illuccix |
| Emd Serono, INC. | $23.29 | 2021 | |
| Sandoz INC. | $22.34 | 2025 | Ziextenzo, Cyclophosphamide |
| Shield Therapeutics INC | $20.16 | 2024 | |
| Foundation Medicine, INC. | $19.67 | 2021 | |
| Epizyme, INC. | $19.60 | 2022 | |
| Coherus Oncology, INC. | $19.58 | 2021 | |
| Spectrum Pharmaceuticals INC. | $16.84 | 2025 | Rolvedon |
| Recordati_rare_diseases_inc. | $15.74 | 2023 | Sylvant |
Drugs and devices associated with these payments
Keytruda $421Enhertu $352Tecvayli $261Darzalex $258Libtayo $250Lenvima $229Zejula $228Lynparza $213Talvey $200Jemperli $195Fotivda $191Scemblix $189Besremi $181Pluvicto $174Imfinzi $151Kisqali $141Jaypirca $134Verzenio $134Cabometyx $128Inqovi $120Lonsurf $120Erleada $114Retevmo $111Epkinly $102Doptelet $99.38Elahere $87.66Poteligeo $84.93Monjuvi $81.23Orserdu $80.26Jakafi $74.88Nubeqa $74.66Keytruda Qlex $74.16Carvykti $72.72Vitrakvi $72.44Stivarga $72.44Lutathera $71.89Xermelo $68.56Fabhalta $68.25Rezlidhia $66.79Tavalisse $66.79Calquence $64.94Tukysa $63.07Orgovyx $60.39Xpovio $58.28Tazverik $57.51Arista Ah Flexitip $56.76Xofigo $55.25Zynlonta $49.76Jevtana $49.13Tivdak $48.69Zoladex $48.63Pyrukynd $48.36Gavreto $47.43Monoferric $47.34Injectafer $46.82Illuccix $46.70Imbruvica $46.28Vectibix $45.60Xgeva $45.60Nplate $45.60Ogsiveo $44.02Brukinsa $43.67Cosela $43.65Pemazyre $43.42Venclexta $43.18Akeega $42.18Fruzaqla $41.00Welireg $40.71Therasphere Y90 Glass Microspheres 10 Gbq $40.67Zynyz $37.81Adcetris $37.76Blincyto $37.54Kyprolis $37.54Krazati $35.45Nerlynx $33.92Cresemba $33.89Ultomiris $33.20Qinlock $28.83Emrelis $25.93Ninlaro $25.72Braftovi $24.75Lorbrena $24.75Mektovi $24.75Stimufend $24.43Alecensa $24.14Rozlytrek $24.14Avastin $24.14Tecentriq $24.14Pemgarda $23.64Tabrecta $23.52Vanflyta $23.47Vpriv $23.45Ziextenzo $22.34Cyclophosphamide $22.34Elrexfio $21.91Tasigna $21.34Mekinist $20.99Somatuline Depot $20.64Onivyde $20.64Accrufer $20.16
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Plate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.